These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2436759)

  • 21. Correlation of suppressed natural killer cell activity with altered host resistance models in B6C3F1 mice.
    Wilson SD; McCay JA; Butterworth LF; Munson AE; White KL
    Toxicol Appl Pharmacol; 2001 Dec; 177(3):208-18. PubMed ID: 11749120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-2 (IL-2) activated natural killer (A-NK) cells: binding to microvascular endothelial cells and BRM enhancement of cytolytic activity.
    Brunson KW; Ohashi M; Miller CA; Kitson RP; Basse PH; Goldfarb RH
    In Vivo; 1994; 8(1):71-5. PubMed ID: 8054514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
    Gorelik E; Gunji Y; Herberman RB
    J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
    Peace DJ; Kern DE; Schultz KR; Greenberg PD; Cheever MA
    J Immunol; 1988 May; 140(10):3679-85. PubMed ID: 2896213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of suppressor cells in the decline of natural killer cell activity in estrogen-treated mice.
    Milisauskas VK; Cudkowicz G; Nakamura I
    Cancer Res; 1983 Nov; 43(11):5240-3. PubMed ID: 6225513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural killing in estrogen-treated mice responds poorly to poly I.C despite normal stimulation of circulating interferon.
    Seaman WE; Merigan TC; Talal N
    J Immunol; 1979 Dec; 123(6):2903-5. PubMed ID: 227961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmentation of human natural killer cell activity by polyinosinic acid-polycytidylic acid and its nontoxic mismatched analogues.
    Zarling JM; Schlais J; Eskra L; Greene JJ; Ts'o PO; Carter WA
    J Immunol; 1980 Apr; 124(4):1852-7. PubMed ID: 6154082
    [No Abstract]   [Full Text] [Related]  

  • 28. Activation of murine natural killer cells and macrophages by 8-bromoguanosine.
    Koo GC; Jewell ME; Manyak CL; Sigal NH; Wicker LS
    J Immunol; 1988 May; 140(9):3249-52. PubMed ID: 2452203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conditioned augmentation of natural killer cell activity. Independence from nociceptive effects and dependence on interferon-beta.
    Solvason HB; Ghanta VK; Hiramoto RN
    J Immunol; 1988 Jan; 140(2):661-5. PubMed ID: 2826599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concanavalin a injection activates intrahepatic innate immune cells to provoke an antitumor effect in murine liver.
    Miyagi T; Takehara T; Tatsumi T; Suzuki T; Jinushi M; Kanazawa Y; Hiramatsu N; Kanto T; Tsuji S; Hori M; Hayashi N
    Hepatology; 2004 Nov; 40(5):1190-6. PubMed ID: 15486936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor.
    Benczur M; Petrányl GG; Pálffy G; Varga M; Tálas M; Kotsy B; Földes I; Hollán SR
    Clin Exp Immunol; 1980 Mar; 39(3):657-62. PubMed ID: 6155232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetics, regulation, and specificity of murine natural antitumor antibodies and natural killer cells.
    Chow DA; Wolosin LB; Greenberg AH
    J Natl Cancer Inst; 1981 Aug; 67(2):445-53. PubMed ID: 6943381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells.
    Laybourn KA; Hiserodt JC; Abruzzo LV; Varani J
    Cancer Res; 1986 Jul; 46(7):3407-12. PubMed ID: 2939945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of natural killer activity with tumorigenesis of a preneoplastic mouse mammary lesion.
    Wei WZ; Fulton A; Winkelhake J; Heppner G
    Cancer Res; 1989 May; 49(10):2709-15. PubMed ID: 2785436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow.
    Wiltrout RH; Pilaro AM; Gruys ME; Talmadge JE; Longo DL; Ortaldo JR; Reynolds CW
    J Immunol; 1989 Jul; 143(1):372-8. PubMed ID: 2732472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection.
    Salazar-Mather TP; Ishikawa R; Biron CA
    J Immunol; 1996 Oct; 157(7):3054-64. PubMed ID: 8816415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of natural killer effector and suppressor activity by intraepithelial lymphocytes from mouse small intestine.
    Mowat AM; Tait RC; MacKenzie S; Davies MD; Parrott DM
    Clin Exp Immunol; 1983 Apr; 52(1):191-8. PubMed ID: 6222852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of dietary restriction and aging on natural killer cell activity in mice.
    Weindruch R; Devens BH; Raff HV; Walford RL
    J Immunol; 1983 Feb; 130(2):993-6. PubMed ID: 6600261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
    Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
    Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of cytolytic activity and interferon-gamma production in murine natural killer cells by polymyxins B and E.
    Zhong M; Kadota Y; Shimizu Y; Gohda E
    Int Immunopharmacol; 2008 Mar; 8(3):508-13. PubMed ID: 18279806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.